| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
EVP, Chief Financial Officer | SVP, Acting CFO | SVP, Finance and CAO +2 more
1 company
Mueller Brian serves as an EVP, Chief Financial Officer at BMRN. Across recent SEC filings that breaks down to 0 buys and 25 sells. Those positions are worth an estimated $6.9M at current prices.
Historically, Mueller Brian's trades have earned a middling insider score of 64/100 across 10 rated trades. Over a 12-month horizon, 70.0% of those trades were profitable, with an average 12-month return of +6.5%.
The biggest single holding is BMRN (~$6.9M) as EVP, Chief Financial Officer. The recent filings there lean toward selling, a net 80,927 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| May 30, 2024 | BMRN Biomarin Pharmaceutical Inc | EVP, Chief Financial Officer | Sale+OE10b5-1 | 5,000 | $75.19 | $375,950.00 | -6.5% | +21.3% | -22.0% | |
| Jan 13, 2023 | BMRN Biomarin Pharmaceutical Inc | EVP, Chief Financial Officer | Sale+OE | 2,500 | $114.50 | $286,250.00 | -8.3% | -12.8% | -17.2% | |
| Dec 13, 2022 | BMRN Biomarin Pharmaceutical Inc | EVP, Chief Financial Officer | Sale+OE | 2,500 | $107.50 | $268,750.00 | -8.3% | -15.9% | -8.0% | |
| Dec 2, 2022 | BMRN Biomarin Pharmaceutical Inc | EVP, Chief Financial Officer | Sale+OE | 7,001 | $104.50 | $731,604.50 | -20.1% | -5.2% | -12.4% | |
| Nov 23, 2022 | BMRN Biomarin Pharmaceutical Inc | EVP, Chief Financial Officer | Sale+OE | 5,379 | $98.73 | $531,091.56 | -15.7% | +8.4% | -9.8% | |
| Aug 5, 2022 | BMRN Biomarin Pharmaceutical Inc | EVP, Chief Financial Officer | Sale+OE | 3,500 | $94.50 | $330,750.00 | -10.2% | -11.4% | -7.6% | |
| Jul 8, 2022 | BMRN Biomarin Pharmaceutical Inc | EVP, Chief Financial Officer | Sell | 7,337 | $89.50 | $656,661.50 | -19.3% | +2.8% | -4.4% | |
| May 4, 2022 | BMRN Biomarin Pharmaceutical Inc | EVP, Chief Financial Officer | Sale+OE | 11,800 | $84.50 | $997,100.00 | -23.4% | +2.4% | +12.8% | |
| May 7, 2021 | BMRN Biomarin Pharmaceutical Inc | EVP, Chief Financial Officer | Sale+OE | 6,709 | $79.50 | $533,365.50 | -17.6% | +0.2% | +1.9% | |
| Apr 1, 2021 | BMRN Biomarin Pharmaceutical Inc | EVP, Chief Financial Officer | Sell | 5,692 | $76.30 | $434,299.60 | -15.5% | +7.2% | +1.9% |